醣類對梭狀芽孢桿菌生產有機溶劑的影響

Effect of Carbohydrates on the Production of Organic Solvents by Clostridium beijerinckii

林正倫(Cheng-Lun Lin)

指導教授 ： 官宜靜 ； 許垤綦

大同大學/工程學院/生物工程學系所/碩士(2007年)

摘要

由於石油能源逐漸枯竭，能源再生成為各國積極探索的研究與發展重心。利用細菌以農業廢棄物生產可利用的有機溶劑，進行能源再生，為常見的生質能生產方法之一，兼具廢棄物回收處理與能源生產的雙重效益。本研究主要探討梭狀芽孢桿菌（Clostridium beijerinckii）在分別添加五種不同醣類（木糖、麥芽糖、阿拉伯糖、葡萄糖和乳糖），進行ABE（acetone-butanol-ethanol）發酵時，各種醣類的利用情形以及ABE的生產多寡。由GC-FID和GC-MS分析結果顯示，添加木糖或乳糖於培養中，可獲得較多的butanol和ethanol。

關鍵字

梭狀芽孢桿菌 ； 生質能

並列摘要

Because petroleum resource is very limited and will be exhausted sooner or later, renewable energy has been the focus of research and development in many countries. The production of useful organic solvents from agricultural wastes by bacteria is one of the methods commonly used for energy production from biomass. In this way, not only does it recycle wastes but also produces energy. The main goal of this study is to examine the carbohydrate consumption and production of ABE in the cultures of Clostridium beijerinckii when different carbohydrate (xylose, maltose, arabinose, glucose or lactose ) was supplemented. Analysis of GC-FID和GC-MS indicated that addition of xylose or lactose resulted in higher production of butanol and ethanol.

並列關鍵字

ABE

參考文獻

蕭嘉瑢，複合基質厭氧氫醱酵生物程序控制之功能評估及分生檢測生態之研究，成功大學環境工程學系碩士論文，台南 （2004）

Ezeji, T.C., Qureshi, N., Blaschek, H.P. （2005）Continuous butanol fermentation and feed starch retrogradation:butanol fermentation sustainability using Clostridium beijerinckii BA101. J. Biotechnol. 115: 179–187.

Kalil, M. S., Kit, P. W., Wan Yusoff, W., Sadazo, Y. and Rahman, R. A. (2003) Direct Fermentation of palm oil mill effluent to acetone-butanol-ethanol by solvent producing Clostridia. Pak. J. Biol. Sci. 6: 1273-1275.

Parek, M., Formane, J., Blasche, H. P. （1999） Pilot-scale production of butanol by Clostridium beijerinckii BA101 using a low-cost fermentation medium based on corn steep water. Appl. Microbiol. Biotechnol. 51：152-157.

Honey, D., Caylor, C., Luthi, R., and Kerrigan S. (2005) Comparative alcohol concentrations in blood and vitreous fluid with illustrative case studies. J. Anal. Toxicol. 29: 365-369.